Image

Stereotactic Body Radiation Therapy for Inoperable Non-metastasized Pancreatic Adenocarcinoma

The purpose of this study is to evaluate Stereotactic Body Radiation Therapy for Inoperable Pancreatic Adenocarcinoma

Recruiting
18 years and older
All
Phase N/A
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates inoperable non-metastasized pancreatic adenocarcinoma. It evaluates the use of stereotactic body radiation therapy (SBRT) in combination with chemotherapy to improve outcomes for patients with this condition.

The study focuses on assessing the safety and effectiveness of combining SBRT with chemotherapy. It evaluates progression-free survival and other outcomes related to patient quality of life and treatment safety.

  • Who can participate: Participants must be over 18 years old with inoperable, non-metastasized pancreatic adenocarcinoma and have adequate organ function with an ECOG performance status of 0-2.
  • Study details: Participants will undergo chemotherapy, with some also receiving SBRT.
  • Study timelines and visits: The study will last 110 weeks. The study requires 11 visits.
Print
Study details
    Non-metastasized Unresectable Pancreatic Carcinoma

NCT06691425

Cancer Research Antwerp

31 July 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.